# To Evaluate the Efficacy of DDB/Garlic Oil in Patients With Elevated Transaminase Chronic Liver Disease

> **NCT02347319** · PHASE4 · COMPLETED · sponsor: **PharmaKing** · enrollment: 262 (actual)

## Conditions studied

- Chronic Liver Disease

## Interventions

- **DRUG:** Pennel
- **DRUG:** Legalon
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02347319
- **Lead sponsor:** PharmaKing
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-05
- **Final completion:** 2013-06
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2015-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02347319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02347319, "To Evaluate the Efficacy of DDB/Garlic Oil in Patients With Elevated Transaminase Chronic Liver Disease". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02347319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*